Chronic pulmonary aspergillosis kills about 80 percent of those suffering from it over five years unless it is treated with long-term antifungals. The European Respiratory Society estimates that 3 million people worldwide have CPA. The infection is particularly difficult to manage and the societies expect these clinical guidelines to be a helpful resource for those treating affected patients.
“This is the first guideline on chronic pulmonary aspergillosis worldwide,” Andrew Ullman, a professor at the Julius Maximilian University of Würzberg and chairman of the ESCMID’s fungal infection study group, said in a statement. “It is the result of another joint effort of ESCMID and ERS experts who, in a truly interdisciplinary collaboration, prepared and published guidance for colleagues on a group of complex diseases that is difficult to manage. Aspergillosis is more than chronic lung infection and a larger document addressing all aspects of aspergillosis infections is under preparation by EFISG.”
More articles on infection control:
CDC: Source of UPMC mold that killed 3 could not be found
FDA relaxes ban on blood donations from gay, bisexual men
WHO publishes list of emerging diseases like to cause major epidemics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
